[HTML][HTML] A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) …
Population factors such as age, gender, ethnicity, genotype and disease state can cause
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
[PDF][PDF] Mayur K. Ladumor, Aarzoo Thakur1, Sheena Sharma1, Aravind Rachapally1, Sarang Mishra1, Priyanka Bobe1, V. Kameswara Rao1, Praneetha Pammi1, Hari …
B Prasad, S Singh - academia.edu
Results Compilation of DMET protein abundance data. We compiled literature reported
protein abundance data of 55 DMEs (30 Phase I and 25 Phase II) and 104 membrane …
protein abundance data of 55 DMEs (30 Phase I and 25 Phase II) and 104 membrane …
[HTML][HTML] A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) …
MK Ladumor, A Thakur, S Sharma, A Rachapally… - Scientific …, 2019 - ncbi.nlm.nih.gov
Population factors such as age, gender, ethnicity, genotype and disease state can cause
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling …
MK Ladumor, A Thakur, S Sharma, A Rachapally… - Scientific …, 2019 - europepmc.org
Population factors such as age, gender, ethnicity, genotype and disease state can cause
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling …
MK Ladumor, A Thakur, S Sharma… - Scientific …, 2019 - ui.adsabs.harvard.edu
Population factors such as age, gender, ethnicity, genotype and disease state can cause
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling …
MK Ladumor, A Thakur, S Sharma… - Scientific …, 2019 - search.ebscohost.com
Population factors such as age, gender, ethnicity, genotype and disease state can cause
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling …
MK Ladumor, A Thakur, S Sharma… - Scientific …, 2019 - pubmed.ncbi.nlm.nih.gov
Population factors such as age, gender, ethnicity, genotype and disease state can cause
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
[PDF][PDF] Mayur K. Ladumor, Aarzoo Thakur1, Sheena Sharma1, Aravind Rachapally1, Sarang Mishra1, Priyanka Bobe1, V. Kameswara Rao1, Praneetha Pammi1, Hari …
B Prasad, S Singh - academia.edu
Results Compilation of DMET protein abundance data. We compiled literature reported
protein abundance data of 55 DMEs (30 Phase I and 25 Phase II) and 104 membrane …
protein abundance data of 55 DMEs (30 Phase I and 25 Phase II) and 104 membrane …
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling …
MK Ladumor, A Thakur, S Sharma, A Rachapally… - Scientific …, 2019 - europepmc.org
Population factors such as age, gender, ethnicity, genotype and disease state can cause
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …
inter-individual variability in pharmacokinetic (PK) profile of drugs. Primarily, this variability …